Jumonji regulates cardiomyocyte proliferation via interaction with retinoblastoma protein

Jooyoung Jung1, Tae-Gyun Kim, Gary E Lyons

  • 1Department of Anatomy, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA.

Insights

Jumonji (JMJ) protein represses cell growth by interacting with the retinoblastoma protein (Rb), inhibiting cell cycle progression. This interaction is crucial for normal embryonic development, particularly in heart formation.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cell Cycle Regulation

Background:

  • Jumonji (JMJ) is a transcriptional repressor involved in embryonic development, including heart development.
  • The precise molecular mechanisms by which JMJ influences cell growth remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying Jumonji's role in cell growth regulation.
  • To investigate the interaction between JMJ and the retinoblastoma protein (Rb) in controlling cell cycle progression.

Main Methods:

  • Co-immunoprecipitation to assess JMJ-Rb interaction.
  • Reporter gene assays to evaluate E2F activity and cell cycle gene promoter activity.
  • Primary cardiomyocyte culture from jmj knock-out mouse embryos.

Main Results:

  • JMJ directly interacts with the retinoblastoma protein (Rb).
  • JMJ enhances Rb-mediated repression of E2F activity, reducing cell cycle progression.
  • jmj knock-out cardiomyocytes exhibit increased mitosis and up-regulated expression of cell cycle regulators (cyclin D1, D2, Cdc2).

Conclusions:

  • JMJ down-regulates cell growth through its interaction with Rb, impacting cell cycle control.
  • These findings provide insights into the cardiac defects observed in jmj mutant mice and highlight JMJ's role in cardiomyocyte proliferation.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...